1. Home
  2. WKHS vs NXL Comparison

WKHS vs NXL Comparison

Compare WKHS & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$5.38

Market Cap

17.4M

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.71

Market Cap

18.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
NXL
Founded
2007
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
18.6M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
WKHS
NXL
Price
$5.38
$0.71
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$21.00
$5.00
AVG Volume (30 Days)
225.4K
210.8K
Earning Date
11-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$156,931.00
Revenue This Year
$92.70
$38.28
Revenue Next Year
$34.00
$185.71
P/E Ratio
N/A
N/A
Revenue Growth
16.73
N/A
52 Week Low
$5.01
$0.54
52 Week High
$118.50
$3.87

Technical Indicators

Market Signals
Indicator
WKHS
NXL
Relative Strength Index (RSI) 58.28 42.89
Support Level $5.20 $0.71
Resistance Level $6.00 $0.80
Average True Range (ATR) 0.40 0.08
MACD -0.18 0.02
Stochastic Oscillator 35.35 60.74

Price Performance

Historical Comparison
WKHS
NXL

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: